{"id":227893,"date":"2026-09-02T13:56:49","date_gmt":"2026-09-02T08:26:49","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=227893"},"modified":"2026-09-02T13:56:49","modified_gmt":"2026-09-02T08:26:49","slug":"why-piramal-pharma-ltd-share-price-rise-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-rise-today-2026\/","title":{"rendered":"Piramal Pharma Ltd. (PPLPHARMA) Share Price Rises 2.11% Today"},"content":{"rendered":"
Piramal Pharma Ltd. (PPLPHARMA)<\/a> share price rose to Rs 217.7 today, up 2.11% from the previous close. Market cap was Rs 28,550.76 crore.<\/em><\/div>\n

Piramal Pharma Ltd. Share Price rose to Rs 217.7, up 2.11% today, taking market capitalisation to Rs 28,550.76 crore.<\/p>\n

Piramal Pharma Ltd. Share Price was in focus on 02 September 2026 after the stock climbed Rs 4.5 to Rs 217.7 from the previous close of Rs 213.2. The stock opened at Rs 211.05, traded between Rs 211.05 and Rs 217.7, and turnover stood at Rs 3.39 crore. The supplied data confirms a same-day rise, but it does not identify a company-specific trigger, so the useful lens is price behaviour plus the company\u2019s valuation and profitability profile.<\/p>\n

That profile is mixed. The company\u2019s market capitalisation of Rs 28,550.76 crore is well above the same-industry median market cap of Rs 720.34 crore and above the same-industry average of Rs 14,208.71 crore across 201 benchmark companies. However, profitability remains weak on the supplied numbers: ROE is -4.04, ROCE is 1.24, EPS is Rs -2.36 and dividend yield is 0. Its P\/B ratio is 3.55 against an industry median of 2.88 and industry average of 4.35, which places valuation above the middle of the benchmark set on book value, even though return metrics trail industry norms.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n